|
KMID : 1022220210100040292
|
|
Clinical Nutrition Research
2021 Volume.10 No. 4 p.292 ~ p.302
|
|
|
Irisin Acts via the PGC-1α and BDNF Pathway to Improve Depression-like Behavior
|
|
Jo Dan-Bi
Song Ju-Hyun
|
|
|
Abstract
|
|
|
|
Depression is the most prevalent psychiatric disorder experienced by the world's population. Mechanisms associated with depression-like behavior have not been fully investigated. Among the therapeutic solution for depression, exercise is considered an important regulator attenuating depressive neuropathology. Exercise has been reported to boost the secretion of myokines such as irisin and myostatin in skeletal muscles. Myokines secreted during exercise are involved in various cellular responses including the endocrine and autocrine systems. Especially, irisin as a cleaved version of fibronectin domain-containing protein 5 has multiple functions such as white fat-browning, energy expenditure increase, anti-inflammatory effects, and mitochondrial function improvement in both systemic circulation and central nervous system. Furthermore, irisin activates energy metabolism-related signaling peroxisome proliferator-activated receptor-gamma coactivator-1 alpha and memory formation-related signaling brain-derived neurotrophic factor involved in depression. However, the role and mechanism of irisin in depression disorder is not obvious until now. Here, we review recent evidences regarding the therapeutic effect of irisin in depression disorder. We suggest that irisin is a key molecule that suppresses several neuropathological mechanisms involved in depression.
|
|
|
KEYWORD
|
|
|
Irisin, Depression, Energy metabolism, Brain-derived neurotrophic factor (BDNF), Peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α)
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|